| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |